c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EST
UTC-5 New York
Blue Chip
Log in
Sign up
Compass Therapeutics’ chief accounting officer Neil Lerner buys $5,900 in stock
Investing.com | Nov 18, 2026 9:01 AM EST
Read original article